Bionano Genomics, Inc. (BNGO) Financials
BNGO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 158.0 million | 75.2 million |
2023-12-31 | 214.4 million | 118.2 million |
2023-09-30 | 181.9 million | 62.9 million |
2023-06-30 | 271.4 million | 56.6 million |
BNGO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -28.2 million | 3.0 million |
2023-12-31 | -35.0 million | 3.4 million |
2023-09-30 | -26.4 million | 4.0 million |
2023-06-30 | -37.2 million | 3.9 million |
BNGO Net Income
No data available :(
BNGO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 52.8 million | - | - |
2023-12-31 | 101.9 million | - | 9.6 million |
2023-09-30 | 63.6 million | - | 10.1 million |
2023-06-30 | 77.1 million | - | 10.7 million |
BNGO Shares Outstanding
BNGO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 26000 | 9.8 million | - | - |
2023-12-31 | 745000 | 11.7 million | 15.7 million | - |
2023-09-30 | 75000 | 13.8 million | 24.9 million | - |
2023-06-30 | 511000 | 14.6 million | 26.9 million | - |
BNGO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 8.8 million | 5.9 million |
2023-12-31 | 10.7 million | 8.3 million |
2023-09-30 | 9.3 million | 6.6 million |
2023-06-30 | 8.7 million | 6.4 million |
BNGO
Price: $1.14
52 week price:
Earnings Per Share: -6.81 USD
P/E Ratio: -0.16
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 6.9 million
Market Capitalization: 63.9 million